| Literature DB >> 25172243 |
Jia Pei Lim1, Jérôme Devaux2, Nobuhiro Yuki3.
Abstract
Guillain-Barré syndrome is classified into acute inflammatory demyelinating polyneuropathy and acute motor axonal neuropathy. Whereas autoantibodies to GM1 or GD1a induce the development of acute motor axonal neuropathy, pathogenic autoantibodies have yet to be identified in acute inflammatory demyelinating polyneuropathy and chronic inflammatory demyelinating polyneuropathy. This review highlights the importance of autoantibodies to peripheral nerve proteins in the physiopathology of acute and chronic inflammatory demyelinating polyneuropathies. Moreover, we listed up other potential antigens, which may become helpful biomarkers for acquired, dysimmune demyelinating neuropathies based on their critical functions during myelination and their implications in hereditary demyelinating neuropathies.Entities:
Keywords: Acute inflammatory demyelinating polyneuropathy; Autoantibody; Charcot–Marie–Tooth disease; Chronic inflammatory demyelinating polyneuropathy; Experimental autoimmune neuritis; Guillain–Barré syndrome
Mesh:
Substances:
Year: 2014 PMID: 25172243 DOI: 10.1016/j.autrev.2014.08.005
Source DB: PubMed Journal: Autoimmun Rev ISSN: 1568-9972 Impact factor: 9.754